Form 8-K

8-K — Park Dental Partners, Inc.

Accession: 0001104659-26-060312

Filed: 2026-05-13

Period: 2026-05-13

CIK: 0002069604

SIC: 8090 (SERVICES-MISC HEALTH & ALLIED SERVICES, NEC)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — tm2614439d1_8k.htm (Primary)

EX-99.1 — EXHIBIT 99.1 (tm2614439d1_ex99-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: tm2614439d1_8k.htm · Sequence: 1

false

0002069604

2026-05-13

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

May 13, 2026

Park Dental Partners,

Inc.

(Exact name of registrant as specified in its

charter)

Minnesota

001-42967

93-2020683

(State or other jurisdiction of

(Commission File Number)

(I.R.S. Employer

incorporation or organization)

Identification Number)

2200 County Road C West, Suite 2210

Roseville, Minnesota 55113

(651) 633-0500

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive

offices)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities

Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange

Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under

the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under

the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)

of the Act:

Title of each class

Trading Symbol

Name of each exchange on which

registered

Common Stock, par value $0.0001 per share

PARK

The Nasdaq Capital Market

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth

company x

If an emerging

growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any

new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

Item 2.02 Results of Operations and Financial Condition.

On May 13, 2026, Park Dental Partners, Inc. (the “Company”)

issued a press release on the Company’s website announcing its first quarter 2026 financial results for the reporting period ended

March 31, 2026. On May 14, 2026, the Company will host its quarterly earnings conference call, which will be accessible to the

public.

A copy of the Company’s press release is furnished as Exhibit 99.1

and is attached to this Current Report on Form 8-K. The information in this Item 2.02 and Exhibit 99.1 shall not be deemed “filed”

for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into

any filings under the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Exhibit

99.1

Press Release dated May 13, 2026 of Park Dental Partners, Inc.

104

Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed

on its behalf by the undersigned hereunto duly authorized.

Date: May 13, 2026

PARK

DENTAL PARTNERS, INC.

By:

/s/ Christopher J. Bernander

Name: Christopher J. Bernander

Title: Chief Financial Officer

EX-99.1 — EXHIBIT 99.1

EX-99.1

Filename: tm2614439d1_ex99-1.htm · Sequence: 2

Exhibit 99.1

Park Dental Partners Announces First Quarter 2026 Results

FOR IMMEDIATE RELEASE

Minneapolis, Minn. — May 13, 2026 — Park Dental Partners, Inc.

(NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,”

“our,” “us,” or the “Company”) today reported its first-quarter financial results for 2026.

Summary financial results are listed below and in the accompanying supplemental financial tables.

(Unaudited,

in millions, except per share data, and Doctor counts)

Three Months

Ended

March 31,

2026

2025

Change

Revenue

62.7

59.0

6.2

Gross Margin

6.4

9.9

(35.3

Gross Margin percentage

10.2

16.7

(650

)bps

Net Income (Loss)

(0.4

)

1.6

(124.9

Diluted EPS

(0.09

)

0.88

(0.97

)

Adjusted

Gross Margin(a)

12.2

11.9

2.6

Adjusted

Gross Margin Percentage(a)

19.5

20.2

(70

)bps

Adjusted

EBITDA(b)

4.7

5.5

(13.2

Adjusted

EBITDA margin(b)

7.6

9.3

(170

)bps

Adjusted

Diluted EPS(c)

0.44

1.14

(0.70

)

Same Practice Revenue Growth

4.1

1.2

290

bps

Practicing Affiliated Doctors

221

203

8.9

(a) See Non GAAP Reconciliation of Gross Margin to Adjusted Gross Margin

below

(b) See Non GAAP Reconciliation of Net Income (Loss) to Adjusted EBITDA

below

Earnings Per Share below

Executive Commentary – Pete Swenson, Chief Executive Officer

and Chair of the Board of Directors

“We delivered a solid start to 2026, with revenue increasing

6.2% year over year, driven by strong same practice performance and continued patient demand. Results were consistent with our expectations

and reflect continued execution against our operating plan. We continue to invest in recruiting, staffing, and clinical capacity to support

long-term growth.

With strong liquidity and a flexible balance sheet, we remain well

positioned to execute on our growth strategy, including expanding current practices and adding new practices through disciplined acquisitions

and de novo expansion.”

Financial Results – First Quarter 2026

· Revenue increased 6.2% over the prior year’s comparable quarter to $62.7 million, due to increased patient visits and

growth in clinical hours, the impact of acquisitions, and reimbursement growth. Same practice revenue growth was 4.1%. Revenue from

acquisitions in the past 12 months contributed approximately $0.8 million in the quarter.

· Total

General Practice revenue grew 6.4% over the prior year’s comparable quarter to $46.1

million. Total Multi-Specialty Practice revenue grew 5.7% to $16.6 million.

· Cost

of services was $56.3 million, an increase of $7.1 million above the prior year’s comparable

quarter, driven primarily by share-based

compensation recorded in the quarter, and growth in doctors and team members.

· General

and administrative costs were $7.8 million, an increase of $0.9 million above the prior year’s

comparable quarter. The primary driver of these increases was share-based compensation, acquisition-related

costs, and public company costs, net of lower IPO preparation costs related to our 2025 offering.

· Net

loss was $(0.4) million, compared to net income of $1.6 million in the prior year comparable quarter,

primarily driven by increased salaries and benefits, and share-based compensation, partially

offset by revenue growth, tax benefits on share-based compensation, and operating leverage.

· Adjusted

EBITDA was $4.7 million, or 7.6% of revenue, compared to $5.5 million, or 9.3% of revenue

in the prior year comparable quarter.

· Adjusted

diluted earnings per share were $0.44 versus $1.14 in the prior year’s comparable quarter,

due primarily to the increase in shares issued and vested during the IPO.

Affiliated Practice Updates

· As

of March 31, 2026, we supported 86 affiliated practices and 221 affiliated doctors.

· First

quarter patient retention rate was 90.1%.

· Patient

visits increased to 178,527 across our affiliated dental practices.

· During

the first quarter our affiliated dental practices completed one general practice acquisition

in Tucson, Arizona, as previously announced on January 23, 2026. The acquired practices’

impact on revenues and net earnings was not material for the quarter.

Balance Sheet, Liquidity, and Cash Flow

· Cash

and cash equivalents were $24.4 million as of March 31, 2026.

· Total

debt outstanding was approximately $11.5 million as of March 31, 2026, and our $15 million

line of credit was undrawn at quarter end.

· Total

shares outstanding were 4.5 million shares as of the end of the quarter.

· We

generated $5.0 million in operating cash flow in the first quarter, a decrease of $0.8 million

compared to the prior year comparable quarter due primarily to changes in working capital.

· First

quarter capital investments were $2.3 million.

Full-Year 2026 Outlook

First quarter results were consistent with our expectations, and we

are maintaining our fiscal 2026 outlook range. Our outlook excludes the impact of any future practice affiliations or acquisitions that

have not yet closed. As a result, actual results may differ materially depending on the timing and number of future affiliations, de

novo practice openings, or acquisitions completed during the year.

Year Ending

December 31, 2026

Year Ended

December 31, 2025

Percent

Change

($ in millions)

(Outlook)

(Actual)

(At Midpoint)

Revenue

$254.0

– $258.0

$ 244.5

4.7 %

Adjusted EBITDA

$21.0

– $23.0

$ 22.0

Adjusted EBITDA margin

8.3%

- 8.9%

9.0 %

Our outlook includes 3.5% to 5.0% same practice revenue growth and

approximately $2 million recurring public company costs we expect to incur in 2026. The outlook assumes continued patient demand across

general and specialty services, stable reimbursement trends across commercial and government payors, ongoing recruitment and retention

initiatives, and contributions from recently acquired and affiliated practices and de novos. We continue to monitor patient demand and

labor market trends that could impact our outlook.

Conference Call

As announced on April 24, 2026, the Company will host a conference

call to discuss these results tomorrow morning, Thursday, May 14, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

live webcast of the call will be accessible by registering using the link below or through the Investor Relations section of the Company’s

website at https://investors.parkdentalpartners.com. A replay of the webcast will be available on the website for a limited

time following the call.

About Park Dental Partners, Inc.

Park Dental Partners, Inc., and its subsidiaries (NASDAQ:PARK)

is a dental resource organization that has put patients first since the establishment of its general dentistry group in 1972. The Company

provides comprehensive business support services, including clinical team members, administrative personnel, facilities, and equipment,

to its affiliated general and multi-specialty dental practices. The Company has 221 affiliated doctors across 86 practice locations in

three states. The Company’s clinical support team consists of approximately 990 hygienists, dental assistants, and patient care

coordinators that support affiliated doctors in operating their practices. The mission of our affiliated dental practices since inception

has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind

our organization today.

Park Dental Partners is based in Roseville, Minnesota. For more information,

please visit parkdentalpartners.com.

Basis of Consolidation

In accordance with generally accepted accounting principles in the

United States, we consolidate the net assets and results of operations of the affiliated dental practices operating under long-term administrative

resource agreements with us. As a result, references to our revenues, our expenses and similar items relating to our results of operations

and net assets includes the revenues, expenses and similar items of our affiliated dental practices and all transactions between the

affiliated dental practices and us, such as the service fees we charge, are eliminated in consolidation.

Forward Looking Statements

Certain statements in this press release are “forward-looking

statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities

Exchange Act of 1934, as amended, with respect to the Company’s financial condition, results of operations, plans, objectives,

future performance and business. Forward-looking statements include those preceded by, followed by or that include the words “believes,”

“expects,” “anticipates,” “intends,” “estimates,” “plans,” “may,”

“will,” or similar expressions. These forward-looking statements involve risks and uncertainties. Actual results may differ

materially from those contemplated by such forward-looking statements because of, among other things, potential risks and uncertainties,

such as:

· Regulatory

and compliance risk, including state dental corporate practice of dentistry and fee-splitting

restrictions, HIPAA and other privacy/cybersecurity obligations, and evolving healthcare

and labor regulations;

· Reimbursement

risk, including risks related to payer mix, reimbursement rates, audit/recoupment activity,

enrollment and collections timing, and dependence on significant third-party payors;

· Our

ability to identify, acquire, integrate and effectively support affiliated practices and

to execute de novo expansion, and the risk of undiscovered liabilities in acquisitions;

· Dependence

on affiliated dental practices and their clinical performance; our ability to attract, hire

and retain dentists, specialists and hygienists; and risks related to ownership transitions

of affiliated entities;

· Competition

for patients and clinicians in our markets and the impact on patient volumes and staffing;

· Macroeconomic

conditions, inflation and interest rates, and our geographic concentration, particularly

in the markets we operate.

A forward-looking statement is neither a prediction nor a guarantee

of future events or circumstances, and those future events or circumstances may not occur. We are under no obligation, and we expressly

disclaim any obligation, to update or alter any forward-looking statements, whether because of new information, future events or otherwise.

Non-GAAP Financial Measures

This news release and the related conference call include presentation

of Non-GAAP measures that include or exclude special items of a nonrecurring and/or nonoperational nature. Management believes that the

Non-GAAP measures provide useful information to investors regarding the Company’s results of operations and financial condition

because they permit a more meaningful comparison and understanding of Park Dental Partners, Inc’s operating performance for

the current, past or future periods. Management uses these Non-GAAP measures to monitor and evaluate ongoing operating results and trends

and to gain an understanding of the comparative operating performance of the Company.

Please note that the Company has not provided the most directly comparable

GAAP financial measure, or a quantitative reconciliation thereto, for the Adjusted EBITDA forward-looking guidance for 2026 included

in this press release in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. Providing

the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, cannot be done without unreasonable effort

due to the inherent uncertainty and difficulty in predicting certain non-cash, material and/or non-recurring expenses or benefits; legal

settlements or other matters; and certain tax positions. The variability of these items could have an unpredictable, and potentially

significant, impact on our future GAAP financial results.

See Supplemental non-GAAP financial tables below for a reconciliation

of adjusted non-GAAP financial measures to GAAP.

Company Contact Information

Investor Contact:

Park Dental Partners Investor Relations Team

763-233-3377

ir@parkdentalpartners.com

Media Contact:

Park Dental Partners Media Relations Team

651-633-0500

marketing@parkdentalpartners.com

Supplemental Financial Tables

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

(in thousands, except share and per share amounts)

Three

Months Ended March 31,

2026

2025

REVENUE

$ 62,695

$ 59,037

COST OF SERVICES

Salaries and benefits

41,895

35,637

Dental supplies and Laboratory fees

4,338

4,239

Office occupancy

4,285

4,004

Other practice expenses

3,834

3,405

Depreciation

1,963

1,896

TOTAL COST OF SERVICES

56,315

49,181

GROSS MARGIN

6,380

9,856

General and administrative expenses

7,840

6,928

Depreciation and amortization

420

378

OPERATING INCOME (LOSS)

(1,880 )

2,550

INTEREST EXPENSE - NET

(121 )

(337 )

INCOME (LOSS) BEFORE TAX

(2,001 )

2,213

PROVISION/(BENEFIT) FOR INCOME TAX

(1,611 )

646

NET INCOME (LOSS)

$ (390 )

$ 1,566

EARNINGS (LOSS) PER SHARE:

Basic

$ (0.09 )

$ 0.88

Diluted

$ (0.09 )

$ 0.88

Basic weighted-average number of common

shares outstanding

4,383,073

1,783,352

Diluted weighted-average number of common

shares outstanding

4,383,073

1,783,352

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEET (unaudited)

(in thousands)

March 31,

December 31,

2026

2025

ASSETS

Cash and cash equivalents

$ 24,372

$ 25,185

Accounts receivable – net of allowance

6,819

6,991

Other current assets

6,531

5,726

Total current assets

37,722

37,902

OTHER ASSETS:

Property and equipment and lease assets

73,945

73,828

Goodwill and Intangible assets, nets

29,793

28,360

Other assets

38,397

38,093

Total other assets

142,135

140,281

TOTAL ASSETS

$ 179,857

$ 178,183

LIABILITIES AND DEFICIT

Accounts payable and other accrued liabilities

$ 6,682

$ 6,291

Payroll, benefits and short term deferred compensation

16,802

16,716

Current portion of debt and lease liabilities

8,730

8,606

Deferred Revenue and other current liabilities

3,084

4,120

Total current liabilities

35,298

35,733

LONG-TERM LIABILITIES:

Deferred compensation

67,569

68,417

Long-term debt and lease liabilities

51,016

51,744

Other long-term liabilities

537

486

Total long-term liabilities

119,122

120,647

TOTAL LIABILITIES

$ 154,420

$ 156,380

Total shareholders’ equity

$ 25,437

$ 21,803

TOTAL LIABILITIES AND SHAREHOLDERS’

EQUITY

$ 179,857

$ 178,183

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

(in thousands)

For the Three Months Ended

March 31,

2026

2025

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income (loss)

$ (390 )

$ 1,566

Adjustments to reconcile net income

(loss) to net cash flows from operating activities:

Depreciation and amortization

2,383

2,274

Deferred income taxes

(470 )

—

Change in cash surrender value of life

insurance

440

335

Noncash lease and loss on disposal of

equipment

(15 )

Share based compensation

4,024

—

Changes in operating

assets and liabilities

(992 )

1,699

Net cash flows from operating activities

5,026

5,859

NET CASH FLOWS USED IN INVESTING ACTIVITIES:

Purchases of property and equipment

$ (2,305 )

$ (2,420 )

Life insurance premiums paid

(273 )

(664 )

Payments for purchases of dental practices

(1,595 )

—

Issuance of notes

to related parties

(600 )

—

Net cash flows used in investing activities

(4,773 )

(3,084 )

CASH FLOWS USED IN FINANCING ACTIVITIES:

Dental practice purchase installment

payments

$ (8 )

Net change in checks issued in excess

of cash balances

(573 )

(1,328 )

Net proceeds (payments) on debt and

capital leases

(485 )

(489 )

Cash paid for

Share Repurchase

—

(154 )

Net cash flows

used in financing activities

(1,066 )

(1,979 )

NET CHANGE IN CASH AND CASH EQUIVALENTS

(813 )

796

CASH AND CASH EQUIVALENTS – Beginning

of year

25,185

2,672

CASH AND CASH EQUIVALENTS - End of

year

$ 24,372

$ 3,468

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

RECONCILIATION OF GROSS MARGIN TO ADJUSTED

GROSS MARGIN (unaudited)

(in thousands)

Three

Months Ended March 31,

2026

2025

GROSS MARGIN

$ 6,380

10.2 %

$ 9,856

16.7 %

Addback:

Share based compensation

3,665

5.8 %

0.0 %

Restructuring

costs1

0.1 %

Deferred compensation

160

0.3 %

0.1 %

Depreciation

1,963

3.1 %

1,896

3.2 %

ADJUSTED GROSS MARGIN

$ 12,205

$ 11,900

ADJUSTED GROSS MARGIN PERCENTAGE

19.5 %

20.2 %

1 Restructuring costs primarily consist of expenses

incurred in connection with the Company’s initial public offering.

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED

EBITDA (unaudited)

(in thousands)

For the Three Months Ended

March 31,

2026

2025

NET INCOME (LOSS)

$ (390 )

(0.6 )%

$ 1,566

2.7 %

Addback:

Provision/(Benefit) for income tax

(1,611 )

(2.6 )%

646

1.1 %

Interest expense, net

121

0.2 %

337

0.6 %

Depreciation and amortization

2,383

3.8 %

2,274

3.9 %

EBITDA

$ 503

0.8 %

$ 4,823

8.2 %

Adjustments:

Share based compensation

4,024

6.4 %

0.0 %

Restructuring costs1

0.1 %

557

0.9 %

Deferred compensation

160

0.3 %

0.1 %

ADJUSTED EBITDA

$ 4,745

7.6 %

$ 5,465

9.3 %

1 Restructuring costs primarily consist of expenses

incurred in connection with the Company’s initial public offering.

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

RECONCILIATION OF EARNINGS (LOSS) PER SHARE

TO ADJUSTED EARNINGS PER SHARE (unaudited)

(in thousands, except share and per share amounts)

For the Three Months Ended

March 31,

2026

2025

EARNINGS (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS:

$ (390 )

$ 1,566

Adjustments:

Share based compensation

4,024

Restructuring costs

557

Deferred compensation

160

Income

tax effect of the Adjustments1

(1,188 )

(180 )

ADJUSTED NET INCOME ATTRIBUTABLE TO

COMMON STOCKHOLDERS

$ 2,664

$ 2,028

Adjusted Weighted Average Diluted Shares -

Reconciliation

WEIGHTED-AVERAGE SHARES USED IN COMPUTING GAAP NET LOSS PER

SHARE, DILUTED

4,383,073

1,783,352

ADJUSTED

WEIGHTED AVERAGE DILUTED SHARES USED IN COMPUTING ADJUSTED EARNINGS PER SHARE, DILUTED2

6,059,839

1,783,352

ADJUSTED DILUTED EARNINGS PER SHARE:

$ 0.44

$ 1.14

1 Income tax effect is based on an estimated long-term

annual effective tax rate of 28% tax rate for the three months ended March 31, 2026 and March 31, 2025. The Company’s

estimated long-term annual effective tax rate excludes certain non-cash items such as share based compensation arrangements, and is used

in order to provide consistency across periods.

2 Includes an additional 1,584,666 of weighted average

dilutive shares and 92,100 of weighted average dilutive warrants for the three months ended March 31, 2026, that are excluded from

a GAAP perspective due to the Company’s net loss in that reporting period.

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

CONSOLIDATED OPERATING METRICS (unaudited)

For the Three Months Ended

March 31,

2026

2025

Patient Visits1

178,527

175,940

Same Practice Revenue Growth2

4.1 %

1.2 %

Patient Retention Rate3

90.1 %

89.2 %

Doctor Count4

221

203

1 A patient visit is counted when service is provided

to a patient at one of our affiliated dental general dentistry practices. Measuring the year-over-year change in patient visits helps

us to evaluate how the affiliated dental practices are performing. It also helps with evaluating demand for services which influences

decision-making relating to matters such as appropriate staffing levels and recruiting needs. In addition, it influences decision-making

processes relating to our marketing, sales and advertising strategies and helps us with evaluating the effectiveness of those strategies.

Further, with respect to continuing care patient count, it allows us to evaluate the ability of affiliated dentists to encourage patients

to complete their diagnosed dental treatment plans.

2 Same practice revenues represent total revenues for

same dental practice locations that have been operating for at least 13 full months prior to the end of a given reporting period and

which have not been closed, or sold during such period. Measuring the year-over-year change in same practice revenues allows us to evaluate

how affiliated dental practices are performing. We believe various factors affect comparable practice revenues, including patient demand

for dental services, economic trends, dentist and hygienist staffing levels, availability of dentists and hygienists, pricing, competition,

visibility and accessibility of the dental practices, quality of the tenants surrounding the dental practices, clinical hours and the

level of patient service provided inside and outside of the dental practices.

3 Patient retention rate is calculated by counting patients

that remain active at the beginning and end of a twelve-month period. Active patients are defined as general dentistry patients having

been seen by our affiliated dental practices within the past 36 months, or last 18 months for patients under the age of 18. Patients

who have not been seen by our affiliated dental practices within these time periods are removed from our active patient lists. This methodology

is aligned with ADA clinical procedure codes, and is consistent with treatment protocols for new patients, before being considered an

active patient again. Measuring the year-over-year and quarter-over-quarter change in patient retention allows us to evaluate the recurring

nature of patient visits at the dental practices and affiliated dentists which influences decision-making around matters such as appropriate

levels of staffing, recruiting, advertising and facility expansion opportunities.

4 Dentists operating in one of our affiliated dental

practices are included in this calculation, which includes both full and part-time dentists. Measuring the year-over-year and quarter-over-quarter

change in dentist count allows us to evaluate the production capacity of affiliated dental practices. It also influences decision-making

relating to matters such as appropriate staffing levels and recruiting needs.

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

May 13, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

May 13, 2026

Entity File Number

001-42967

Entity Registrant Name

Park Dental Partners,

Inc.

Entity Central Index Key

0002069604

Entity Tax Identification Number

93-2020683

Entity Incorporation, State or Country Code

Entity Address, Address Line One

2200 County Road C West

Entity Address, Address Line Two

Suite 2210

Entity Address, City or Town

Roseville

Entity Address, State or Province

Entity Address, Postal Zip Code

55113

City Area Code

651

Local Phone Number

633-0500

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, par value $0.0001 per share

Trading Symbol

PARK

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

true

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration